V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 10121867 | 10063655 | 1.75 | 96.2 | null | 2020-01-29 | 2020-04-16 | Avelumab | 02 | null | CARBOPLATIN + GEMCITABINE | 101375454 |
| 10121934 | 10063656 | 1.58 | null | null | 2020-06-30 | 2020-11-07 | RUXOLITINIB | 02 | null | RUXOLITINIB | 100117349 |
| 10123704 | 10063657 | 1.62 | 103 | null | 2019-11-17 | 2019-12-08 | RUXOLITINIB | 02 | N | RUXOLITINIB | 100728530 |
| 10124951 | 10063658 | 1.72 | 97.2 | null | 2021-12-16 | 2021-12-30 | Venetoclax | 02 | N | VENETOCLAX | 100266071 |
| 10126275 | 10063659 | 1.64 | 62.2 | Palliative (P) | 2017-04-06 | 2017-04-07 | Venetoclax | 02 | N | VENETOCLAX | 101494062 |
| 10126468 | 10063660 | 1.61 | 68.7 | null | 2021-04-17 | 2021-04-17 | CEMIPLIMAB | 02 | null | CEMIPLIMAB | 100006212 |
| 10131685 | 10063661 | 1.73 | 71 | Palliative (P) | 2018-04-11 | 2018-04-11 | Venetoclax | 02 | N | VENETOCLAX | 101420687 |
| 10132630 | 10063662 | 1.58 | 51.4 | Palliative (P) | 2021-04-05 | 2021-07-13 | GEMCARBO | 02 | N | CARBOPLATIN + GEMCITABINE | 100174718 |
| 10133018 | 10063663 | 1.75 | 50.3 | null | 2019-10-09 | 2019-10-09 | Irinotecan + Modified De Gramont | 02 | null | BENDAMUSTINE + RITUXIMAB | 101090201 |
| 10135790 | 10063664 | 1.74 | 69 | null | 2019-09-07 | 2019-09-07 | RUXOLITINIB | 02 | null | RUXOLITINIB | 101571969 |
| 10136760 | 10063665 | 1.69 | 53 | null | 2017-02-17 | 2017-02-22 | CARBOPLATIN + GEMCITABINE | 02 | null | CARBOPLATIN + GEMCITABINE | 101681809 |
| 10138617 | 10063667 | 1.77 | 75.7 | Curative (C) | 2016-05-19 | 2017-04-01 | NIVOLUMAB | 02 | N | NIVOLUMAB | 101005405 |
| 10140465 | 10063669 | 1.75 | 87.6 | Adjuvant (A) | 2018-12-10 | 2018-12-30 | Avelumab | 02 | N | BENDAMUSTINE + RITUXIMAB | 100642987 |
| 10140587 | 10063670 | 1.65 | 81 | 03 | 2022-02-15 | 2022-02-16 | Avelumab | 02 | N | BENDAMUSTINE + RITUXIMAB | 101591233 |
| 10141993 | 10063671 | 1.74 | 71.8 | null | 2019-03-21 | 2019-03-26 | CEMIPLIMAB | 02 | null | CEMIPLIMAB | 100468665 |
| 10143751 | 10063672 | 1.62 | 69.9 | null | 2021-07-07 | 2021-07-07 | Avelumab | 02 | null | FLUOROURACIL + IRINOTECAN | 100323751 |
| 10144018 | 10063673 | null | 84.4 | Palliative (P) | 2021-04-20 | 2021-05-13 | FLUOROURACIL + OXALIPLATIN | 02 | N | FLUOROURACIL + OXALIPLATIN | 101026683 |
| 10145200 | 10063675 | 1.65 | 0 | Palliative (P) | 2016-09-10 | 2017-04-21 | DARATUMUMAB | 02 | N | DARATUMUMAB | 101485495 |
| 10146407 | 10063676 | 1.83 | 58 | 03 | 2020-11-04 | 2020-11-05 | Avelumab | 02 | N | BENDAMUSTINE + RITUXIMAB | 100737526 |
| 10153052 | 10063678 | 0 | 82.4 | null | 2020-03-24 | 2020-05-11 | Trastuzumab | 02 | null | TRASTUZUMAB | 100733124 |
| 10153291 | 10063679 | 1.62 | 90 | 03 | 2016-06-02 | 2016-06-02 | Avelumab | 02 | N | FLUOROURACIL + IRINOTECAN | 100982627 |
| 10154257 | 10063680 | 1.7 | 91.4 | Palliative (P) | 2021-10-18 | 2021-10-26 | DARATUMUMAB | 02 | N | DARATUMUMAB | 100391765 |
| 10156279 | 10063682 | 1.69 | 64.7 | 03 | 2019-07-27 | 2019-08-17 | CEMIPLIMAB | 02 | N | CEMIPLIMAB | 100321772 |
| 10158411 | 10063683 | 1.62 | 68 | Palliative (P) | 2019-08-19 | 2019-09-14 | Avelumab | 02 | N | TRASTUZUMAB | 101659045 |
| 10161709 | 10063684 | 1.65 | 78.8 | Palliative (P) | null | 2020-07-05 | Trastuzumab Subcutaneous | 02 | N | FLUOROURACIL + IRINOTECAN | 100645879 |
| 10162796 | 10063685 | 1.61 | 0 | Palliative (P) | 2021-11-27 | 2021-12-07 | NIVOLUMAB | 02 | N | NIVOLUMAB | 100570563 |
| 10164254 | 10063687 | 1.58 | null | null | null | 2020-10-05 | Avelumab | 02 | N | FLUOROURACIL + OXALIPLATIN | 101460626 |
| 10168334 | 10063688 | 1.81 | 70 | null | 2020-10-06 | 2021-01-19 | Avelumab | 02 | null | AVELUMAB | 101071948 |
| 10168630 | 10063689 | 1.76 | 0 | null | null | 2022-03-28 | Avelumab | 02 | null | FLUOROURACIL + IRINOTECAN | 100214267 |
| 10169424 | 10063690 | 1.71 | 74.6 | Palliative (P) | 2018-06-02 | 2018-06-12 | DARATUMUMAB | 02 | N | DARATUMUMAB | 100660211 |
| 10170001 | 10063691 | 1.71 | 58 | Palliative (P) | null | 2020-09-03 | CEMIPLIMAB | 02 | null | CEMIPLIMAB | 101077469 |
| 10170837 | 10063692 | 0 | 88 | null | 2019-07-14 | 2019-10-21 | Avelumab | 02 | null | FLUOROURACIL + OXALIPLATIN | 101050963 |
| 10172489 | 10063694 | 1.53 | 62.2 | Palliative (P) | 2021-07-27 | 2021-08-12 | CARBOPLATIN + GEMCITABINE | 02 | N | CARBOPLATIN + GEMCITABINE | 100806076 |
| 10173154 | 10063695 | 1.72 | 78 | null | null | 2019-05-13 | Trastuzumab Subcutaneous | 02 | null | TRASTUZUMAB | 100549958 |
| 10173655 | 10063696 | 1.91 | 62.3 | Palliative (P) | null | 2021-02-19 | Avelumab | 02 | N | BENDAMUSTINE + RITUXIMAB | 101284343 |
| 10176151 | 10063697 | 1.79 | 91.3 | Palliative (P) | 2020-08-15 | 2020-11-07 | DARATUMUMAB | 02 | N | DARATUMUMAB | 101107491 |
| 10176800 | 10063698 | 1.68 | 56.2 | Palliative (P) | 2020-08-28 | 2020-09-02 | NIVOLUMAB | 02 | N | NIVOLUMAB | 100693276 |
| 10178801 | 10063699 | 1.67 | 93.8 | null | null | 2022-04-11 | FLUOROURACIL + OXALIPLATIN | 02 | null | FLUOROURACIL + OXALIPLATIN | 100545570 |
| 10180375 | 10063700 | 1.74 | 0 | null | 2019-07-03 | 2019-07-08 | DARATUMUMAB | 02 | null | DARATUMUMAB | 100642351 |
| 10183708 | 10063701 | 1.82 | 94.2 | null | 2016-02-24 | 2017-05-26 | Avelumab | 02 | null | VENETOCLAX | 100426929 |
| 10184840 | 10063703 | null | 86.1 | null | 2019-04-26 | 2019-04-26 | Avelumab | 02 | null | AVELUMAB | 100263333 |
| 10185620 | 10063704 | 1.71 | 67.6 | 03 | 2020-10-27 | 2021-12-04 | Avelumab | 02 | N | RUXOLITINIB | 100948685 |
| 10186199 | 10063705 | null | 54.8 | Palliative (P) | 2018-05-10 | 2019-06-17 | RUXOLITINIB | 02 | N | RUXOLITINIB | 101743237 |
| 10191357 | 10063706 | 1.7 | 80.9 | Adjuvant (A) | 2020-01-22 | 2020-02-21 | NIVOLUMAB | 02 | N | CARBOPLATIN + GEMCITABINE | 100572795 |
| 10192451 | 10063707 | null | 75 | Palliative (P) | 2021-04-22 | 2021-04-22 | GEMCARBO | 02 | N | CARBOPLATIN + GEMCITABINE | 100690251 |
| 10192863 | 10063708 | 1.72 | 82 | Adjuvant (A) | 2017-10-13 | 2017-11-17 | Avelumab | 02 | N | BENDAMUSTINE + RITUXIMAB | 100364497 |
| 10194450 | 10063709 | 1.86 | 68.4 | null | 2017-07-23 | 2017-09-19 | Avelumab | 02 | null | NIVOLUMAB | 100889408 |
| 10195063 | 10063710 | 1.82 | 86.1 | Adjuvant (A) | 2020-09-13 | 2020-09-21 | Avelumab | 02 | N | RUXOLITINIB | 101337089 |
| 10197738 | 10063711 | 1.74 | 91 | Palliative (P) | 2022-01-03 | 2022-01-03 | NIVOLUMAB | 02 | N | NIVOLUMAB | 100371119 |
| 10198299 | 10063712 | 1.77 | 58.1 | Adjuvant (A) | 2020-05-01 | 2021-03-30 | Avelumab | 02 | N | AVELUMAB | 100140889 |